Koninklijke Philips (PHG) EBITDA Margin (2009 - 2026)
Koninklijke Philips' (PHG) quarterly EBITDA Margin came in at 6.17% in Q1 2026, up 241.0% year-on-year from 1.81% in Q1 2025, and down 41.75% quarter-over-quarter from 10.59% in Q4 2025.
Koninklijke Philips (PHG) EBITDA Margin (2009 - 2026) Analysis & Trends
Koninklijke Philips' EBITDA Margin history runs 18 years deep, the most recent figure standing at 6.17% for Q1 2026.
- On a quarterly basis, EBITDA Margin rose 241.0% year-over-year to 6.17% in Q1 2026; TTM through Mar 2026 was 9.41%, a 536.0% decrease from a year earlier, with the FY2025 full-year figure at 7.98%, up 505.0% from the prior year.
- EBITDA Margin slipped to 6.17% in Q1 2026 per PHG's latest filing, from 10.59% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.3% in Q4 2024 and bottomed at 28.2% in Q4 2022.
- The 5-year median for EBITDA Margin is 12.77% (2025), against an average of 8.81%.
- Across the five-year window, EBITDA Margin plunged 3148 bps in 2022 and soared 4590 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 28.2% in 2022, then jumped by 163 bps to 17.7% in 2023, then advanced by 15 bps to 20.3% in 2024, then plunged by 48 bps to 10.59% in 2025, then tumbled by 42 bps to 6.17% in 2026.
- Per Business Quant, the three latest PHG EBITDA Margin figures stand at 6.17% (Q1 2026), 10.59% (Q4 2025), and 7.67% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.17% |
| Dec 31, 2025 | 10.59% |
| Sep 30, 2025 | 7.67% |
| Jun 30, 2025 | 12.77% |
| Mar 31, 2025 | 3.76% |
| Dec 31, 2024 | 20.30% |
| Sep 30, 2024 | 16.79% |
| Jun 30, 2024 | 16.43% |
| Mar 31, 2024 | 14.72% |
| Dec 31, 2023 | 17.70% |
| Sep 30, 2023 | 15.50% |
| Jun 30, 2023 | 15.23% |
| Mar 31, 2023 | 13.80% |
| Dec 31, 2022 | -28.20% |
| Sep 30, 2022 | 10.81% |
| Jun 30, 2022 | 0.26% |
| Mar 31, 2022 | -4.62% |
| Dec 31, 2021 | 3.28% |
| Sep 30, 2021 | 17.78% |
| Jun 30, 2021 | 0.78% |